205 related articles for article (PubMed ID: 15495023)
21. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
[TBL] [Abstract][Full Text] [Related]
22. Psychological interventions for non-ulcer dyspepsia.
Soo S; Moayyedi P; Deeks J; Delaney B; Lewis M; Forman D
Cochrane Database Syst Rev; 2001; (4):CD002301. PubMed ID: 11687157
[TBL] [Abstract][Full Text] [Related]
23. WITHDRAWN: Initial management strategies for dyspepsia.
Delaney B; Ford AC; Forman D; Moayyedi P; Qume M
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD001961. PubMed ID: 19821286
[TBL] [Abstract][Full Text] [Related]
24. WITHDRAWN: Medical treatments in the short term management of reflux oesophagitis.
Moayyedi P; Santana J; Khan M; Preston C; Donnellan C
Cochrane Database Syst Rev; 2011 Feb; (2):CD003244. PubMed ID: 21328259
[TBL] [Abstract][Full Text] [Related]
25. Medical treatments in the short term management of reflux oesophagitis.
Khan M; Santana J; Donnellan C; Preston C; Moayyedi P
Cochrane Database Syst Rev; 2007 Apr; (2):CD003244. PubMed ID: 17443524
[TBL] [Abstract][Full Text] [Related]
26. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
[TBL] [Abstract][Full Text] [Related]
27. Initial management strategies for dyspepsia.
Delaney BC; Moayyedi P; Forman D
Cochrane Database Syst Rev; 2003; (2):CD001961. PubMed ID: 12804417
[TBL] [Abstract][Full Text] [Related]
28. Psychological interventions for non-ulcer dyspepsia.
Soo S; Moayyedi P; Deeks J; Delaney B; Lewis M; Forman D
Cochrane Database Syst Rev; 2005 Apr; (2):CD002301. PubMed ID: 15846636
[TBL] [Abstract][Full Text] [Related]
29. Initial management strategies for dyspepsia.
Delaney BC; Innes MA; Deeks J; Wilson S; Cooner MK; Moayyedi P; Oakes R; Hobbs FD; Forman D
Cochrane Database Syst Rev; 2001; (3):CD001961. PubMed ID: 11687004
[TBL] [Abstract][Full Text] [Related]
30. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
[TBL] [Abstract][Full Text] [Related]
31. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
32. Prokinetics for Functional Dyspepsia: A Systematic Review and Meta-Analysis of Randomized Control Trials.
Pittayanon R; Yuan Y; Bollegala NP; Khanna R; Lacy BE; Andrews CN; Leontiadis GI; Moayyedi P
Am J Gastroenterol; 2019 Feb; 114(2):233-243. PubMed ID: 30337705
[TBL] [Abstract][Full Text] [Related]
33. WITHDRAWN: Psychological interventions for non-ulcer dyspepsia.
Soo S; Moayyedi P; Deeks JJ; Delaney B; Lewis M; Forman D
Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD002301. PubMed ID: 21328255
[TBL] [Abstract][Full Text] [Related]
34. Histamine H2 antagonists for functional dyspepsia: A protocol for a systematic review and meta-analysis.
Li J; Wang F; Lv L; Xu L; Zeng E; Tang X
Medicine (Baltimore); 2019 Nov; 98(47):e18128. PubMed ID: 31764854
[TBL] [Abstract][Full Text] [Related]
35. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials.
Wang WH; Huang JQ; Zheng GF; Xia HH; Wong WM; Liu XG; Karlberg J; Wong BC
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):178-85; quiz 140. PubMed ID: 17174612
[TBL] [Abstract][Full Text] [Related]
36. [Prevention of NSAID induced gastroduodenal ulcers].
Hansen JM; Bytzer P
Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
[TBL] [Abstract][Full Text] [Related]
37. Prevention of NSAID-induced gastroduodenal ulcers.
Rostom A; Dube C; Wells G; Tugwell P; Welch V; Jolicoeur E; McGowan J
Cochrane Database Syst Rev; 2002; (4):CD002296. PubMed ID: 12519573
[TBL] [Abstract][Full Text] [Related]
38. [Drug therapy of non-ulcer dyspepsia].
Bytzer P
Ugeskr Laeger; 1991 Aug; 153(32):2212-6. PubMed ID: 1679263
[TBL] [Abstract][Full Text] [Related]
39. Initial management strategies for dyspepsia.
Delaney BC; Innes MA; Deeks J; Wilson S; Oakes R; Moayyedi P; Hobbs FD; Forman D
Cochrane Database Syst Rev; 2000; (2):CD001961. PubMed ID: 10796841
[TBL] [Abstract][Full Text] [Related]
40. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
